Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ATLANTIC BONE SCREEN logo — Your partner for preclinical research in Oncology, Inflammat...

ATLANTIC BONE SCREEN

Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteoarticular diseases

Founded 2005 France France 24 employees Biotechnology

General Information

Company Name ATLANTIC BONE SCREEN
Founded Year 2005
Location France France +1
Employees 24
Industries Biotechnology
Social

Get notified when ATLANTIC BONE SCREEN moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ATLANTIC BONE SCREEN

Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin. Founded in 2005 by Ronan LE BOT, the CEO of the company, Atlantic Bone Screen is based in Nantes, North-West of France. The company provides a unique preclinical platform with a wide range of assays including in vitro assays with primary cells and cell lines from human and/or animal origin and in vivo assays with reliable animal models reproducing human bone pathologies. Moreover, the company offers histology/histopathology services as well as imaging services such as microCT and X-Ray analyses. Atlantic Bone Screen's expertise extends to the evaluation of biomaterials for orthopedic or dental applications. The company's services support the characterization of drug candidates, nutraceuticals, and biomaterials. In addition to its core services, Atlantic Bone Screen is also associated with sister companies like ATLANCHIM PHARMA, a custom chemical synthesis CRO and ATLANTHERA, a drug discovery company in bone research. Atlantic Bone Screen presents itself as a valuable partner for preclinical research in oncology, inflammation, musculoskeletal disorders, and osteoarticular diseases. With its high-quality offerings and expertise in the biotechnology industry, the company holds significant potential for growth and impact within the field. While specific investment information is not currently available, the company's innovative approach and niche focus make it an intriguing prospect for potential investors and venture capitalists looking for opportunities in the biotechnology sector in the future.

Taxonomy: Preclinical research, Contract Research Organization, Oncology, Inflammation, Musculoskeletal disorders, Osteoarticular diseases, Biomaterials evaluation, In vitro assays, In vivo assays, Histology, Imaging services, Animal models, Tumor cell lines, Drug discovery, Bone and joint diseases

No funding data available for ATLANTIC BONE SCREEN yet.

Get notified when ATLANTIC BONE SCREEN raises funding

ATLANTIC BONE SCREEN Alternatives & Competitors

ATLANTIC BONE SCREEN vs
Pharmatest Services
Pharmatest Services Finland

Pharmatest is a CRO that offers preclinical efficacy services in therapeutic areas of oncology and s...

Private Equity
17 employees
Biotechnology, Pharmaceutical
ATLANTIC BONE SCREEN vs
PharmaLegacy Laboratories
PharmaLegacy Laboratories China

Preclinical Pharmacology CRO

Series C
58 employees
Biotechnology, Health Care
Compare ATLANTIC BONE SCREEN vs PharmaLegacy Laboratories
ATLANTIC BONE SCREEN vs
Biomomentum Inc.
Biomomentum Inc. Canada

Mechanical Testing Solutions for Biomaterials and Tissues

16 employees
Biotechnology, Design

FAQ About ATLANTIC BONE SCREEN

Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteoarticular diseases
ATLANTIC BONE SCREEN was founded in 2005.
ATLANTIC BONE SCREEN is headquartered in France.
ATLANTIC BONE SCREEN operates in the following industries: Biotechnology.
ATLANTIC BONE SCREEN has approximately 24 employees.
Top alternatives and competitors to ATLANTIC BONE SCREEN include Pharmatest Services, PharmaLegacy Laboratories, Biomomentum Inc., Barcelona Liver Bioservices, Neurodigitech, a Neuro-based CRO Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ATLANTIC BONE SCREEN and Pharmatest Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ATLANTIC BONE SCREEN and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes